Viewing nowCombinationBasta Tablet 10/20 (Ezetimibe, Simvastatin)
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
IYun Pharmaceutical Co., Ltd.

MFDS item code 201600928 · Approved 2016.02.18 · Insurance code 658603340
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication is used in conjunction with diet to lower elevated total cholesterol and LDL cholesterol levels in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial, as well as in those with mixed hyperlipidemia. It is administered to patients with homozygous familial hypercholesterolemia when other treatments are ineffective or additional therapy is required. Additionally, this drug helps manage lipid levels in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia. It is essential to use this medication along with an appropriate diet and to first confirm and manage any influence from other health conditions or medications. Regular monitoring of lipid levels before and after treatment is necessary to evaluate effectiveness and adjust as needed. In summary, this medication is employed to improve various types of cholesterol levels associated with hypercholesterolemia and to protect vascular health.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg for 12 months or more without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and monitor closely when administering higher doses to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.
This medication is primarily used to lower blood cholesterol levels and reduce the risk of cardiovascular disease. Care should be taken for muscle-related adverse symptoms such as muscle pain or weakness while taking this medication; if such symptoms occur, consult a physician immediately. The risk of serious muscle damage, including myopathy or rhabdomyolysis, increases particularly when taken at high doses or in conjunction with certain medications. Patients with active liver disease or abnormally high liver enzyme levels should not take this medication. Women who are pregnant or breastfeeding should also avoid this medication, and women of childbearing age should only take it after confirming the possibility of pregnancy. This medication should not be taken with strong CYP3A4 inhibitors such as specific antifungal agents, antibiotics, or antiviral medications, due to increased risk of side effects. Furthermore, it should also be avoided in combination with medications like gemfibrozil, cyclosporine, danazol, and fusidic acid. Caution is necessary for elderly patients, those with decreased kidney function, and patients with hypothyroidism while taking this medication. Regular monitoring of liver function and muscle condition during treatment is recommended, and any adverse symptoms should be reported to healthcare professionals immediately. This medication contains lactose, and patients with lactose intolerance should not take it. Lastly, it is crucial to inform healthcare providers about this medication when being prescribed new drugs during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.
White to off-white, biconvex rectangular tablet
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
IYun Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.